Leeann Urban, CRNA in Anaconda, MT - Anesthesiology

Leeann Urban, CRNA is a Anesthesiology physician based in Anaconda, Montana. Leeann Urban is licensed to practice in Montana (license number RN14371) and her current practice location is 401 W Pennsylvania St, Anaconda, Montana. She can be reached at her office (for appointments etc.) via phone at (406) 563-8500.

NPI number for Leeann Urban is 1508818667 and her current mailing address is 401 W Pennsylvania St, Anaconda, Montana. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1508818667.

Contact Information

	Leeann Urban, CRNA
	401 W Pennsylvania St, Anaconda, MT 59711-1931
	(406) 563-8500
	Not Available

Physician's Profile

Full Name	Leeann Urban
Gender	Female
Speciality	Anesthesiology
Location	401 W Pennsylvania St, Anaconda, Montana
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1508818667
Provider Enumeration Date: 05/17/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Leeann Urban such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1508818667	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	RN14371 (Montana)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Leeann Urban is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Leeann Urban, CRNA 401 W Pennsylvania St, Anaconda, MT 59711-1931 Ph: (406) 563-8500	Leeann Urban, CRNA 401 W Pennsylvania St, Anaconda, MT 59711-1931 Ph: (406) 563-8500

News Archive

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

Researchers develop new method for more accurate testing of anti-cancer drugs

A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg. The method paves the way to much earlier assessment of who benefits from a specific drug and who does not.

New transgenic mouse model sheds light on biological causes of Parkinson's disease

Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.

Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA

Our research uses mathematical modelling to quantify calorie intake as children grow at a healthy rate as well as when they develop obesity. We showed that the development of childhood obesity required a much greater increase in calories than previously thought since prior estimates did not properly account for metabolic changes as children grow.

AERI merges with AHEADD to support communities impacted by Autism Spectrum Disorder

The Autism Education and Research Institute (AERI), an organization committed to providing consultative services that incorporates innovative current research in the field of autism, announces their merging with Achieving in Higher Education with Autism / Developmental Disabilities (AHEADD) in order to support consumers, families, schools, and their surrounding communities who are impacted by Autism Spectrum Disorders (ASD).

Leeann Urban, CRNA - Anesthesiology in Anaconda, MT